StockTipsArenaBeta

BUY Sanofi India Limited — Jefferies India

BUYSanofi India Limited

byJefferies IndiaHorizon: NA (inferred 1 year)28 Jul 2026via CNBC Awaaz.

Entry₹3,370Inferred
Target₹3,500
Total upside +3.86%
Stop lossNot given
CMP₹3,104.22h ago
Active-7.89%+12.75%upside left 11 mo left
Follow Jefferies India for new calls(100% target hit, 28 closed calls)Get alertsWatch SANOFI for new buy/sell callsGet alertsSee 3 other Long-term calls on SANOFISee 108 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 9 Sept, 6:47 pm IST
7 supporting3 opposing
Supports the BUY call (7)

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·24 Jul · 2mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (3)

Sanofi India's petition to quash criminal proceedings dismissed by Supreme Court

NewsCnbc-Tv18·8 Sept · yesterday

(opens in new tab)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·8 Sept · yesterday

Sanofi India Limited received a Show Cause Notice from GST Authorities, disclosed under SEBI (LODR) Regulations, 2015. This may have financial implications.

NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·31 Aug · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.